Michael Silverberg to Viral Load
This is a "connection" page, showing publications Michael Silverberg has written about Viral Load.
Connection Strength
3.411
-
Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care. AIDS Patient Care STDS. 2020 11; 34(11):461-469.
Score: 0.705
-
Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61.
Score: 0.361
-
The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD. J Acquir Immune Defic Syndr. 2024 Nov 01; 97(3):232-241.
Score: 0.233
-
Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS Behav. 2020 Jun; 24(6):1784-1792.
Score: 0.171
-
Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. JAMA Dermatol. 2017 09 01; 153(9):892-896.
Score: 0.142
-
Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390.
Score: 0.141
-
The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System. AIDS Patient Care STDS. 2015 Nov; 29(11):582-90.
Score: 0.125
-
Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85.
Score: 0.121
-
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):413-9.
Score: 0.120
-
HIV infection and incidence of ischemic stroke. AIDS. 2014 Aug 24; 28(13):1911-9.
Score: 0.115
-
Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):160-6.
Score: 0.110
-
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012 Nov 13; 26(17):2223-31.
Score: 0.102
-
The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):321-7.
Score: 0.099
-
Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy. AIDS Res Hum Retroviruses. 2012 Dec; 28(12):1630-6.
Score: 0.098
-
Short-term clinical outcomes among treatment-experienced HIV-positive patients with early low level viremia. AIDS Patient Care STDS. 2012 May; 26(5):253-5.
Score: 0.097
-
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
Score: 0.095
-
New insights into the role of HIV infection on cancer risk. Lancet Oncol. 2009 Dec; 10(12):1133-4.
Score: 0.083
-
Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
Score: 0.057
-
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV. 2022 03; 9 Suppl 1:S2.
Score: 0.048
-
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open. 2021 02 01; 4(2):e2037512.
Score: 0.045
-
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada. Clin Infect Dis. 2020 03 03; 70(6):1176-1185.
Score: 0.042
-
A Flow-Based Model of the HIV Care Continuum in the United States. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):548-553.
Score: 0.035
-
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):568-576.
Score: 0.035
-
Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. Clin Infect Dis. 2017 Aug 15; 65(4):636-643.
Score: 0.035
-
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017 Jul; 17(7):1823-1832.
Score: 0.035
-
End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015 Mar 15; 60(6):941-9.
Score: 0.029
-
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
Score: 0.028
-
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82.
Score: 0.026
-
Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010 Oct 23; 24(16):2469-79.
Score: 0.022
-
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90.
Score: 0.021
-
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008 Apr 23; 22(7):841-8.
Score: 0.019
-
Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens. AIDS Patient Care STDS. 2008 Apr; 22(4):301-12.
Score: 0.018